Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gamida Cell Ltd GMDAQ

Healthcare Biotechnology
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and... see more

Recent & Breaking News (OTCPK:GMDAQ)

Gamida Cell to Present at H.C. Wainwright 6th Annual Israel Conference

Business Wire November 4, 2020

Gamida Cell Announces the Date of Its Third Quarter 2020 Financial Results and Webcast

Business Wire November 2, 2020

Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration

Business Wire October 13, 2020

Gamida Cell to Present at 2020 Virtual Cell & Gene Meeting on the Mesa

Business Wire October 7, 2020

Gamida Cell Announces Positive Topline Data on Secondary Endpoints from Phase 3 Clinical Study of Omidubicel in Patients with Hematologic Malignancies

Business Wire October 6, 2020

Gamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect Meeting

Business Wire September 10, 2020

Gamida Cell to Participate in Upcoming Investor Conferences

Business Wire September 8, 2020

Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September

Business Wire September 3, 2020

Gamida Cell to Provide Webcast of Its Annual Meeting of Stockholders

Business Wire August 17, 2020

Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company Update

Business Wire August 11, 2020

Gamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and Webcast

Business Wire August 4, 2020

Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer

Business Wire July 21, 2020

Gamida Cell Announces Appointment of David Fox to Its Board of Directors

Business Wire July 7, 2020

Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum

Business Wire June 12, 2020

Gamida Cell Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire May 26, 2020

Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update

Business Wire May 21, 2020

Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares

Business Wire May 18, 2020

Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares

Business Wire May 18, 2020

Gamida Cell Announces the Date of Its First Quarter 2020 Financial Results and Webcast

Business Wire May 18, 2020

Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies

Business Wire May 12, 2020